Atherosclerotic Cardiovascular Disease Market Set to Exhibit Growth by 2032, Driven by Advancements and Emerging Therapies
January 24, 2024 10:32 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Atherosclerotic Cardiovascular Disease (ASCVD) - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ...
![American Heart Association Logo](/news-release/logo/213500/0/213500.jpg?lastModified=12%2F09%2F2016%2022%3A55%3A27&size=2)
Stroke Risk High When Anti-Clotting Drugs Stopped
April 25, 2012 13:00 ET
|
American Heart Association
Study Highlights:
Patients with irregular heartbeats who take anti-clotting medications are at high risk of stroke or blood clot whenever the drugs are stopped.
The risks are similar...
![American Heart Association Logo](/news-release/logo/213500/0/213500.jpg?lastModified=12%2F09%2F2016%2022%3A55%3A27&size=2)
AHA Perspective on FDA Committee Decision on Rivaroxaban
September 08, 2011 18:26 ET
|
American Heart Association
DALLAS, Sept. 8, 2011 (GLOBE NEWSWIRE) -- The American Heart Association notes the FDA advisory committee's recommendation today to give market approval for rivaroxaban, an oral anticoagulant drug,...